期刊文献+

大剂量甲氨蝶呤治疗急性淋巴细胞白血病的观察及护理 被引量:2

Observation and Nursing Care for Patients in High-dose Methotrexate Treatment for Acute Lymphocytic Leukemia
在线阅读 下载PDF
导出
摘要 目的探讨大剂量甲氨蝶呤(HDMTX)在急性淋巴细胞白血病(ALL)治疗中的疗效、不良反应及护理措施。方法对17例缓解期ALL患者进行23例次HDMTX(3.0 g/m2)连续24 h静脉输注,同时给予三联鞘内注射,于第36 h甲酰四氢叶酸钙(CF)解救,观察其不良反应并及时对症护理。结果全部患者均能耐受治疗,达持续完全缓解(CCR)。不良反应主要表现为恶心呕吐、口腔黏膜炎、中性粒细胞减少和一过性转氨酶升高等,经对症护理后,均于2周内恢复正常。结论HDMTX治疗ALL是一种安全可行的方法,其中化疗是根本,护理是关键,解救是契机。 Objective To explore the effect and adverse reaction of high-dose methotrexate in the treatment for patients with acute lymphocytic leukemia (ALL) and the nursing interventions. Methods Seventeen cases of ALL in the stage of remission were given high-dose of methotrexate polyglutamate(MTX) intravenous drip for 24 h 23 times in combination with sheath injection of MTX, cytarabine and dexamethasone. Relief was done by citrovorum factor (CF) .after 36 hours. The adverse effects were observed and proper nursing interventions were adopted in time. Results All the patients showed the tolerance for the treatment and reached continuously complete remission(CCR). The manifestations of the adverse effect included vomiting, oral mucosal inflammation, reduction of neutral granulocyte and temporary increase of transaminase. All the adverse reactions disappeared .after proper nursing interventions in 2 weeks. Conclusion The high-dose methotrexate treatment for ALL is effective and safe. The chemotherapy is essential;nursing care is the key;and relief is the turning point.
出处 《解放军护理杂志》 2006年第6期54-55,共2页 Nursing Journal of Chinese People's Liberation Army
关键词 甲氨蝶呤 大剂量 白血病 护理 methotrexate high-dose leukemia nursing
作者简介 陈玉洁(1969-),女,山东人,实验师,本科,主要从事临床护理及实验教学。
  • 相关文献

参考文献4

二级参考文献31

  • 1顾龙君 应大明 等.大剂量氨甲蝶呤对急性淋巴细胞白血病庇护所治疗的探讨[J].中华血液学杂志,1986,7(5):277-286.
  • 2Sonis ST,Van-Vugt AG,McDonald J,et al.Mitigating effect of interleukin-11 on consecutive courses of 5-fluorouracil-induced Ulcerative mucositis in hasters.Cytokine.1997 Aug;9(8):605
  • 3Sonis ST, Muska A, O' Brien J, et al. Alteratio in tle frequincy, Severity and duration of chemotherapy-induced mucositis in hammsters by interleukin-11. Eur-J-Cancer-B-Oral-Oncol. 1995 Jul:31B(4) :261.
  • 4Herrstedt J.Prevention and managment of mucositis in patient with Cancer.Int-J-Antimicrob-Agents.2000 Oct,16(20:161
  • 5Sonis ST,Peterson RL,Edward LJ,et al.Defining mechanisms of action of interleukin-11 on the progression of radiationinduced oral mucositis in hamsters.Oral-Oncol.2000 Jul;36(4):373
  • 6Booth C and Potten CS, Effect of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif.1995;28,28:581.
  • 7Potten CS,Booth D,Haley JD.Pretreatment with transforming growth factor beta-3 protects small intestinal stem cell against radiation damage in vivo.British Journal of Cancer.1997,75(10):1454
  • 8Mc cormack ES,Borzillo GV,Ambrosion C,et al.Transforming Growth Factor-β3 protection of Epithelial cells from cycle-selective chemotherapy in vitro.Biochem-Pharmacol.1997 Apr 25,53(8):1149
  • 9Anderson PM,Schroeder G,Skubitz KM,et al.Oral glutamine reduces the duration and severity of stomatitis after cytotyxic cancer chemotherapy.Cancer.1998 Oct 1;83(7):1433
  • 10Rubio IT,Can Y,Hutchins LF,et al.Effect of glutamine on methotrexate efficacy and toxicity.Ann-Surg.1998 May,227(5):772

共引文献88

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部